This site uses cookies to bring you the best experience. Find out more
Skip to main content

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  


Moa Technology develops groundbreaking category of crop protection

Moa Technology has announced its discovery of chemistries which could become an entirely new category of products to help farmers protect their harvests more safely, sustainably and effectively. Moa has already discovered 80 new herbicidal modes of action with its breakthrough technology platforms in the last three years, several of which are already effectively controlling tough and pervasive weeds in field trials in the US, Canada, France,... Read more

OrganOx acquired by Terumo in landmark $1.5bn deal

The Oxford Science Park warmly congratulates OrganOx Limited on the announcement that it has signed a definitive agreement to be acquired by Terumo Corporation, a global leader in medical technology. The transaction, valued at approximately USD $1.5 billion, marks Terumo’s strategic entry into the organ transplantation-related sector and will see OrganOx become a wholly owned subsidiary. Founded in 2008 as a spinout from the University of... Read more

Santa Ono Joins the Ellison Institute of Technology as EIT Global President

Santa Ono has been appointed to the role of President of EIT Global. Ono has a long and distinguished record of academic leadership having led both the University of British Columbia and the University of Michigan as President. He moved into academic leadership from a distinguished career in biomedical research and immunology. A key part of President Ono’s responsibilities will include working with Sir John Bell, the President of EIT Oxford, in... Read more

Novo Holdings invests in Oxford Nanopore Technologies

Novo Holdings, a leading international life science investor, today announced a £50m investment in Oxford Nanopore Technologies, the leading UK Listed company behind a new generation of molecular sensing technology based on nanopores, located at The Oxford Science Park. Novo Holdings will invest £50m in Oxford Nanopore as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market,... Read more

Approval for first-in-human trial of nerve regeneration technology using spider silk

Newrotex, based at The Oxford Science Park, has received regulatory approval for its first-in-human clinical trial of SilkAxons™, an advanced bioengineered nerve guide which uses the silk of spiders to repair severe peripheral nerve injuries. The trial will be conducted at The Panama Clinic in Panama City, with bioaccess®, Latin America’s leading first-in-human contract research organisation (CRO), managing regulatory and clinical... Read more

The Daubeny Project

Imaginative design, inspiring spaces.